Pulse Biosciences IncNASDAQ:PLSE
- LAST PRICE10.7400
- TODAY'S CHANGE (%)-0.3700 (-3.3303%)
- Bid / Lots7.5000/ 2
- Ask / Lots11.9000/ 6
- Open / Previous Close11.1200 / 11.1100
- Day Range
- 52 Week Range
- Volume232,692
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PLSE |
|---|---|---|
| 09:32 ET | 24956 | 11.12 |
| 09:34 ET | 100 | 11.36 |
| 09:36 ET | 1000 | 11.44 |
| 09:38 ET | 5054 | 11.5 |
| 09:41 ET | 100 | 11.25 |
| 09:43 ET | 1631 | 11.285 |
| 09:45 ET | 100 | 11.35 |
| 10:01 ET | 3690 | 11.2 |
| 10:03 ET | 820 | 11.345 |
| 10:06 ET | 1000 | 11.17 |
| 10:12 ET | 2900 | 11.05 |
| 10:14 ET | 800 | 11.05 |
| 10:15 ET | 200 | 11.19 |
| 10:17 ET | 5227 | 11.17 |
| 10:39 ET | 500 | 11.06 |
| 10:50 ET | 100 | 11 |
| 10:51 ET | 1000 | 10.93 |
| 10:53 ET | 500 | 10.92 |
| 10:57 ET | 100 | 10.81 |
| 11:00 ET | 150 | 10.8186 |
| 11:02 ET | 2780 | 10.8212 |
| 11:06 ET | 3745 | 10.83 |
| 11:08 ET | 1444 | 10.91 |
| 11:09 ET | 146 | 10.8719 |
| 11:31 ET | 100 | 10.82 |
| 11:36 ET | 152 | 10.82 |
| 11:45 ET | 984 | 10.77 |
| 11:54 ET | 206 | 10.7999 |
| 12:02 ET | 100 | 10.74 |
| 12:05 ET | 4983 | 10.775 |
| 12:12 ET | 100 | 10.76 |
| 12:16 ET | 200 | 10.76 |
| 12:20 ET | 7802 | 10.6 |
| 12:23 ET | 100 | 10.73 |
| 12:38 ET | 138 | 10.7 |
| 12:39 ET | 100 | 10.65 |
| 12:41 ET | 966 | 10.64 |
| 12:43 ET | 4500 | 10.63 |
| 12:45 ET | 114 | 10.6 |
| 12:50 ET | 1567 | 10.575 |
| 12:52 ET | 100 | 10.575 |
| 12:59 ET | 893 | 10.44 |
| 01:06 ET | 100 | 10.57 |
| 01:08 ET | 5776 | 10.6 |
| 01:10 ET | 1156 | 10.54 |
| 01:12 ET | 406 | 10.57 |
| 01:14 ET | 130 | 10.575 |
| 01:19 ET | 100 | 10.58 |
| 01:21 ET | 496 | 10.56 |
| 01:28 ET | 1200 | 10.6 |
| 01:32 ET | 900 | 10.6 |
| 01:33 ET | 192 | 10.5875 |
| 01:35 ET | 743 | 10.53 |
| 01:37 ET | 500 | 10.46 |
| 01:44 ET | 100 | 10.49 |
| 01:48 ET | 1100 | 10.515 |
| 01:51 ET | 370 | 10.4708 |
| 01:53 ET | 145 | 10.52 |
| 01:55 ET | 100 | 10.46 |
| 01:57 ET | 150 | 10.485 |
| 02:04 ET | 100 | 10.49 |
| 02:06 ET | 152 | 10.46 |
| 02:08 ET | 100 | 10.43 |
| 02:15 ET | 1371 | 10.445 |
| 02:18 ET | 100 | 10.47 |
| 02:22 ET | 100 | 10.39 |
| 02:24 ET | 147 | 10.445 |
| 02:26 ET | 200 | 10.41 |
| 02:27 ET | 1860 | 10.45 |
| 02:36 ET | 100 | 10.47 |
| 02:38 ET | 152 | 10.49 |
| 02:40 ET | 100 | 10.44 |
| 02:45 ET | 200 | 10.475 |
| 02:49 ET | 109 | 10.43 |
| 02:51 ET | 442 | 10.43 |
| 02:54 ET | 400 | 10.46 |
| 02:56 ET | 100 | 10.455 |
| 03:00 ET | 6215 | 10.49 |
| 03:02 ET | 2000 | 10.5699 |
| 03:03 ET | 500 | 10.615 |
| 03:05 ET | 3098 | 10.74 |
| 03:07 ET | 500 | 10.7 |
| 03:09 ET | 200 | 10.68 |
| 03:14 ET | 100 | 10.68 |
| 03:18 ET | 1200 | 10.795 |
| 03:20 ET | 1573 | 10.795 |
| 03:21 ET | 1405 | 10.72 |
| 03:23 ET | 600 | 10.73 |
| 03:27 ET | 2067 | 10.7 |
| 03:32 ET | 100 | 10.705 |
| 03:34 ET | 511 | 10.67 |
| 03:39 ET | 312 | 10.64 |
| 03:41 ET | 1556 | 10.6 |
| 03:43 ET | 2402 | 10.59 |
| 03:45 ET | 400 | 10.59 |
| 03:48 ET | 600 | 10.55 |
| 03:50 ET | 1899 | 10.615 |
| 03:52 ET | 900 | 10.64 |
| 03:54 ET | 3627 | 10.715 |
| 03:56 ET | 2700 | 10.71 |
| 03:57 ET | 2233 | 10.73 |
| 03:59 ET | 3106 | 10.74 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pulse Biosciences Inc | 593.1M | -13.2x | --- |
Nano-X Imaging Ltd | 403.4M | -6.5x | --- |
Cibus Inc | 254.6M | -0.5x | --- |
Orchestra Biomed Holdings Inc | 226.2M | -4.3x | --- |
MaxCyte Inc | 443.3M | -12.0x | --- |
Vivos Inc | 99.5M | -28.6x | --- |
Company Information
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Contact Information
- Headquarters
- 3957 Point Eden WayHAYWARD, CA, United States 94545-3720
- Phone
- 510-906-4600
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Robert Duggan
- President, Chief Executive Officer, Director
- Burke Barrett
- Chief Technology Officer, Director
- Darrin Uecker
- Chief Commercial Officer
- Kevin Danahy
- Chief Strategy Officer
- Mitchell Levinson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $593.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.75 |
EPS | $-0.82 |
Book Value | $0.80 |
P/E Ratio | -13.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
